SMN2-FL and SMN-Δ7 transcript levels in SMA subjects showed some modest relationships to MHFMS score when the transcripts were assessed in all SMA subjects, including those with a maximum or minimum MHFMS score value (r = 0.34, p = 0.009 for Type II+III only for SMN2-FL; r = 0.60, p = 0.0001 for Type III only for SMN-Δ7). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.